nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—Vasospasm—Carmustine—malignant glioma	0.0641	0.0968	CcSEcCtD
Carboprost Tromethamine—Injection site pain—Carmustine—malignant glioma	0.0268	0.0405	CcSEcCtD
Carboprost Tromethamine—Extravasation—Carmustine—malignant glioma	0.0251	0.0379	CcSEcCtD
Carboprost Tromethamine—Respiratory failure—Temozolomide—malignant glioma	0.0215	0.0325	CcSEcCtD
Carboprost Tromethamine—Phlebitis—Carmustine—malignant glioma	0.0184	0.0279	CcSEcCtD
Carboprost Tromethamine—Eye pain—Carmustine—malignant glioma	0.0176	0.0266	CcSEcCtD
Carboprost Tromethamine—Eye pain—Temozolomide—malignant glioma	0.017	0.0257	CcSEcCtD
Carboprost Tromethamine—Hot flush—Temozolomide—malignant glioma	0.0164	0.0248	CcSEcCtD
Carboprost Tromethamine—Menopausal symptoms—Temozolomide—malignant glioma	0.0163	0.0246	CcSEcCtD
Carboprost Tromethamine—Thirst—Temozolomide—malignant glioma	0.0161	0.0244	CcSEcCtD
Carboprost Tromethamine—Sweating increased—Temozolomide—malignant glioma	0.0129	0.0195	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Temozolomide—malignant glioma	0.0123	0.0186	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Carmustine—malignant glioma	0.0119	0.018	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Temozolomide—malignant glioma	0.0115	0.0174	CcSEcCtD
Carboprost Tromethamine—Tafluprost—PTGS2—malignant glioma	0.0111	1	CrCbGaD
Carboprost Tromethamine—Flushing—Carmustine—malignant glioma	0.0102	0.0154	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Temozolomide—malignant glioma	0.00991	0.015	CcSEcCtD
Carboprost Tromethamine—Flushing—Temozolomide—malignant glioma	0.00986	0.0149	CcSEcCtD
Carboprost Tromethamine—Chills—Temozolomide—malignant glioma	0.00953	0.0144	CcSEcCtD
Carboprost Tromethamine—Back pain—Carmustine—malignant glioma	0.00926	0.014	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Carmustine—malignant glioma	0.00902	0.0136	CcSEcCtD
Carboprost Tromethamine—Back pain—Temozolomide—malignant glioma	0.00895	0.0135	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Temozolomide—malignant glioma	0.00872	0.0132	CcSEcCtD
Carboprost Tromethamine—Angioedema—Temozolomide—malignant glioma	0.00845	0.0128	CcSEcCtD
Carboprost Tromethamine—Vertigo—Temozolomide—malignant glioma	0.00831	0.0126	CcSEcCtD
Carboprost Tromethamine—Hypertension—Carmustine—malignant glioma	0.00826	0.0125	CcSEcCtD
Carboprost Tromethamine—Palpitations—Temozolomide—malignant glioma	0.00817	0.0123	CcSEcCtD
Carboprost Tromethamine—Myalgia—Carmustine—malignant glioma	0.00815	0.0123	CcSEcCtD
Carboprost Tromethamine—Chest pain—Carmustine—malignant glioma	0.00815	0.0123	CcSEcCtD
Carboprost Tromethamine—Anxiety—Carmustine—malignant glioma	0.00812	0.0123	CcSEcCtD
Carboprost Tromethamine—Cough—Temozolomide—malignant glioma	0.00807	0.0122	CcSEcCtD
Carboprost Tromethamine—Hypertension—Temozolomide—malignant glioma	0.00799	0.0121	CcSEcCtD
Carboprost Tromethamine—Myalgia—Temozolomide—malignant glioma	0.00788	0.0119	CcSEcCtD
Carboprost Tromethamine—Anxiety—Temozolomide—malignant glioma	0.00785	0.0119	CcSEcCtD
Carboprost Tromethamine—Infection—Carmustine—malignant glioma	0.00776	0.0117	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Carmustine—malignant glioma	0.00762	0.0115	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Temozolomide—malignant glioma	0.00755	0.0114	CcSEcCtD
Carboprost Tromethamine—Infection—Temozolomide—malignant glioma	0.0075	0.0113	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Temozolomide—malignant glioma	0.0073	0.011	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00712	0.0108	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Carmustine—malignant glioma	0.00701	0.0106	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Carmustine—malignant glioma	0.00696	0.0105	CcSEcCtD
Carboprost Tromethamine—Somnolence—Carmustine—malignant glioma	0.00694	0.0105	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00688	0.0104	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Temozolomide—malignant glioma	0.00678	0.0102	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Temozolomide—malignant glioma	0.00673	0.0102	CcSEcCtD
Carboprost Tromethamine—Somnolence—Temozolomide—malignant glioma	0.00671	0.0101	CcSEcCtD
Carboprost Tromethamine—Pain—Carmustine—malignant glioma	0.00668	0.0101	CcSEcCtD
Carboprost Tromethamine—Pain—Temozolomide—malignant glioma	0.00646	0.00975	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Carmustine—malignant glioma	0.00618	0.00933	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Temozolomide—malignant glioma	0.00597	0.00901	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Carmustine—malignant glioma	0.00576	0.00869	CcSEcCtD
Carboprost Tromethamine—Asthenia—Carmustine—malignant glioma	0.0056	0.00847	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Temozolomide—malignant glioma	0.00556	0.0084	CcSEcCtD
Carboprost Tromethamine—Asthenia—Temozolomide—malignant glioma	0.00542	0.00818	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Carmustine—malignant glioma	0.00535	0.00807	CcSEcCtD
Carboprost Tromethamine—Dizziness—Carmustine—malignant glioma	0.00517	0.0078	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Temozolomide—malignant glioma	0.00517	0.0078	CcSEcCtD
Carboprost Tromethamine—Dizziness—Temozolomide—malignant glioma	0.00499	0.00754	CcSEcCtD
Carboprost Tromethamine—Vomiting—Carmustine—malignant glioma	0.00497	0.0075	CcSEcCtD
Carboprost Tromethamine—Rash—Carmustine—malignant glioma	0.00493	0.00744	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Carmustine—malignant glioma	0.00492	0.00743	CcSEcCtD
Carboprost Tromethamine—Headache—Carmustine—malignant glioma	0.00489	0.00739	CcSEcCtD
Carboprost Tromethamine—Vomiting—Temozolomide—malignant glioma	0.0048	0.00725	CcSEcCtD
Carboprost Tromethamine—Rash—Temozolomide—malignant glioma	0.00476	0.00719	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Temozolomide—malignant glioma	0.00476	0.00718	CcSEcCtD
Carboprost Tromethamine—Headache—Temozolomide—malignant glioma	0.00473	0.00714	CcSEcCtD
Carboprost Tromethamine—Nausea—Carmustine—malignant glioma	0.00464	0.00701	CcSEcCtD
Carboprost Tromethamine—Nausea—Temozolomide—malignant glioma	0.00448	0.00677	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.0042	0.0128	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.00411	0.0126	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—KNG1—malignant glioma	0.00392	0.012	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—malignant glioma	0.00385	0.0118	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—KNG1—malignant glioma	0.00384	0.0117	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—malignant glioma	0.00377	0.0115	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—CXCR3—malignant glioma	0.00364	0.0111	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—CXCR3—malignant glioma	0.00357	0.0109	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—malignant glioma	0.00351	0.0107	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—malignant glioma	0.00343	0.0105	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	0.00333	0.0102	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	0.00326	0.00998	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCR4—malignant glioma	0.0032	0.00978	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCR4—malignant glioma	0.00313	0.00958	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.00312	0.00955	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—malignant glioma	0.00311	0.00951	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.00305	0.00935	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—malignant glioma	0.00304	0.0093	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.00285	0.00873	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.00279	0.00855	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—LATS2—malignant glioma	0.00273	0.00836	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—LATS2—malignant glioma	0.00267	0.00818	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.0026	0.00794	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.00254	0.00778	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—F2—malignant glioma	0.00253	0.00775	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—F2—malignant glioma	0.00248	0.00759	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CXCR3—malignant glioma	0.00238	0.00727	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CXCR3—malignant glioma	0.00233	0.00712	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—F2—malignant glioma	0.00227	0.00693	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—malignant glioma	0.00222	0.00679	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—BDKRB2—malignant glioma	0.00217	0.00665	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—malignant glioma	0.00213	0.00652	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—BDKRB2—malignant glioma	0.00213	0.00651	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—malignant glioma	0.00209	0.00638	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—LATS1—malignant glioma	0.00207	0.00633	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—LATS1—malignant glioma	0.00203	0.0062	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—KNG1—malignant glioma	0.00198	0.00605	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—KNG1—malignant glioma	0.00194	0.00592	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CCR4—malignant glioma	0.00181	0.00553	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CCR4—malignant glioma	0.00177	0.00541	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—malignant glioma	0.0017	0.00521	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.00168	0.00513	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—malignant glioma	0.00167	0.0051	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.00164	0.00503	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCR4—malignant glioma	0.00164	0.00502	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCR4—malignant glioma	0.00161	0.00491	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MDK—malignant glioma	0.0014	0.00428	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MDK—malignant glioma	0.00137	0.00419	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CXCR3—malignant glioma	0.00134	0.00411	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—DTX1—malignant glioma	0.00133	0.00408	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CXCR3—malignant glioma	0.00131	0.00402	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—DTX1—malignant glioma	0.00131	0.004	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—F2—malignant glioma	0.00128	0.00391	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—F2—malignant glioma	0.00125	0.00383	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—BDKRB2—malignant glioma	0.00123	0.00376	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CXCR3—malignant glioma	0.00122	0.00373	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—BDKRB2—malignant glioma	0.0012	0.00368	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CXCR3—malignant glioma	0.00119	0.00365	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.00118	0.00362	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	0.00117	0.00357	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.00116	0.00354	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	0.00114	0.0035	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—PIK3CA—malignant glioma	0.00113	0.00347	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—KNG1—malignant glioma	0.00112	0.00342	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—BDKRB2—malignant glioma	0.00112	0.00341	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—PIK3CA—malignant glioma	0.00111	0.00339	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	0.0011	0.00337	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—KNG1—malignant glioma	0.00109	0.00335	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—BDKRB2—malignant glioma	0.00109	0.00334	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	0.00108	0.0033	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SUFU—malignant glioma	0.00106	0.00324	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HEY2—malignant glioma	0.00105	0.0032	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SUFU—malignant glioma	0.00104	0.00317	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HEY2—malignant glioma	0.00102	0.00314	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GFAP—malignant glioma	0.00102	0.00313	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—KNG1—malignant glioma	0.00101	0.0031	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	0.00101	0.0031	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GFAP—malignant glioma	0.001	0.00306	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—KNG1—malignant glioma	0.000993	0.00304	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	0.000992	0.00303	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SPHK1—malignant glioma	0.000989	0.00303	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCR4—malignant glioma	0.000969	0.00297	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HEY1—malignant glioma	0.000969	0.00297	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SPHK1—malignant glioma	0.000968	0.00296	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HEY1—malignant glioma	0.000949	0.0029	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCR4—malignant glioma	0.000949	0.0029	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HIST1H3B—malignant glioma	0.000942	0.00288	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HIST1H3B—malignant glioma	0.000922	0.00282	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CXCL8—malignant glioma	0.000901	0.00276	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—MMP3—malignant glioma	0.000899	0.00275	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CXCL8—malignant glioma	0.000881	0.0027	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—MMP3—malignant glioma	0.00088	0.00269	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—JAG2—malignant glioma	0.00086	0.00263	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—JAG2—malignant glioma	0.000841	0.00257	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—H3F3A—malignant glioma	0.000727	0.00223	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—F2—malignant glioma	0.000722	0.00221	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CXCR3—malignant glioma	0.00072	0.0022	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—H3F3A—malignant glioma	0.000712	0.00218	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—F2—malignant glioma	0.000707	0.00216	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CXCR3—malignant glioma	0.000705	0.00216	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NTRK2—malignant glioma	0.000701	0.00214	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—YWHAE—malignant glioma	0.000701	0.00214	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FLT1—malignant glioma	0.000698	0.00213	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—DUSP6—malignant glioma	0.000695	0.00213	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CG—malignant glioma	0.000691	0.00211	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NTRK2—malignant glioma	0.000686	0.0021	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—YWHAE—malignant glioma	0.000686	0.0021	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—JAG1—malignant glioma	0.000686	0.0021	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NOTCH3—malignant glioma	0.000683	0.00209	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FLT1—malignant glioma	0.000683	0.00209	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—DUSP6—malignant glioma	0.00068	0.00208	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CG—malignant glioma	0.000677	0.00207	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FBXW7—malignant glioma	0.000672	0.00206	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—JAG1—malignant glioma	0.000671	0.00205	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NOTCH3—malignant glioma	0.000668	0.00205	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—BDKRB2—malignant glioma	0.000659	0.00202	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FBXW7—malignant glioma	0.000658	0.00201	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—F2—malignant glioma	0.000656	0.00201	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—BDKRB2—malignant glioma	0.000645	0.00197	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—F2—malignant glioma	0.000642	0.00196	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AKT2—malignant glioma	0.000632	0.00193	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CG—malignant glioma	0.000628	0.00192	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AKT2—malignant glioma	0.000619	0.00189	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PTPN11—malignant glioma	0.000617	0.00189	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CG—malignant glioma	0.000614	0.00188	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NOTCH2—malignant glioma	0.000613	0.00187	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CD—malignant glioma	0.000608	0.00186	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PTPN11—malignant glioma	0.000604	0.00185	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NOTCH2—malignant glioma	0.0006	0.00183	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—KNG1—malignant glioma	0.000599	0.00183	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000595	0.00182	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—KNG1—malignant glioma	0.000587	0.0018	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AKT2—malignant glioma	0.000574	0.00176	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NTRK1—malignant glioma	0.000571	0.00175	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AKT2—malignant glioma	0.000562	0.00172	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NTRK1—malignant glioma	0.000559	0.00171	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CD—malignant glioma	0.000552	0.00169	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CD—malignant glioma	0.00054	0.00165	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MMP3—malignant glioma	0.000531	0.00162	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CB—malignant glioma	0.00053	0.00162	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CDKN2B—malignant glioma	0.000526	0.00161	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MMP3—malignant glioma	0.00052	0.00159	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000518	0.00159	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CDKN2B—malignant glioma	0.000515	0.00158	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PTK2—malignant glioma	0.000511	0.00156	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CXCL8—malignant glioma	0.000509	0.00156	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HES1—malignant glioma	0.000502	0.00154	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PTK2—malignant glioma	0.0005	0.00153	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NCOR1—malignant glioma	0.000499	0.00153	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CXCL8—malignant glioma	0.000498	0.00152	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—RAF1—malignant glioma	0.000493	0.00151	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HES1—malignant glioma	0.000492	0.0015	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NCOR1—malignant glioma	0.000489	0.0015	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—IL2—malignant glioma	0.000486	0.00149	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—RAF1—malignant glioma	0.000482	0.00148	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CB—malignant glioma	0.000481	0.00147	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PDGFRA—malignant glioma	0.000478	0.00146	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—IL2—malignant glioma	0.000476	0.00146	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CB—malignant glioma	0.000471	0.00144	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PDGFRA—malignant glioma	0.000468	0.00143	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SPP1—malignant glioma	0.000464	0.00142	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CXCL8—malignant glioma	0.000462	0.00141	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SPP1—malignant glioma	0.000454	0.00139	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CXCL8—malignant glioma	0.000452	0.00138	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL2—malignant glioma	0.000442	0.00135	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TERT—malignant glioma	0.00044	0.00135	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL2—malignant glioma	0.000432	0.00132	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TERT—malignant glioma	0.000431	0.00132	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PDGFB—malignant glioma	0.00043	0.00131	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FGFR1—malignant glioma	0.000427	0.00131	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HIF1A—malignant glioma	0.000421	0.00129	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PDGFB—malignant glioma	0.00042	0.00129	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FGFR1—malignant glioma	0.000418	0.00128	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HIF1A—malignant glioma	0.000412	0.00126	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CAV1—malignant glioma	0.000407	0.00125	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—KDR—malignant glioma	0.000402	0.00123	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CAV1—malignant glioma	0.000398	0.00122	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—KDR—malignant glioma	0.000394	0.00121	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—F2—malignant glioma	0.000387	0.00119	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FN1—malignant glioma	0.000387	0.00119	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—BAD—malignant glioma	0.000383	0.00117	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—F2—malignant glioma	0.000379	0.00116	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FN1—malignant glioma	0.000379	0.00116	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NOTCH1—malignant glioma	0.000379	0.00116	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—BAD—malignant glioma	0.000375	0.00115	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CD80—malignant glioma	0.000371	0.00114	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NOTCH1—malignant glioma	0.000371	0.00114	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—APC—malignant glioma	0.000371	0.00113	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PIK3CG—malignant glioma	0.000371	0.00113	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—EGF—malignant glioma	0.000366	0.00112	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PTPN11—malignant glioma	0.000364	0.00111	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CD80—malignant glioma	0.000364	0.00111	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—APC—malignant glioma	0.000363	0.00111	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PIK3CG—malignant glioma	0.000363	0.00111	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—EGF—malignant glioma	0.000359	0.0011	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PTPN11—malignant glioma	0.000357	0.00109	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—BRAF—malignant glioma	0.000349	0.00107	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—BRAF—malignant glioma	0.000341	0.00104	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AKT2—malignant glioma	0.000339	0.00104	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—EGFR—malignant glioma	0.000338	0.00103	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AKT2—malignant glioma	0.000332	0.00102	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—EGFR—malignant glioma	0.000331	0.00101	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PIK3CD—malignant glioma	0.000326	0.000997	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CA—malignant glioma	0.000323	0.000988	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—KRAS—malignant glioma	0.000319	0.000976	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PIK3CD—malignant glioma	0.000319	0.000976	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CA—malignant glioma	0.000316	0.000967	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—KRAS—malignant glioma	0.000312	0.000956	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FGF2—malignant glioma	0.000312	0.000955	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FGF2—malignant glioma	0.000305	0.000935	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CA—malignant glioma	0.000293	0.000897	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MDM2—malignant glioma	0.000292	0.000893	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RAF1—malignant glioma	0.000291	0.00089	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ERBB2—malignant glioma	0.000288	0.000881	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CA—malignant glioma	0.000287	0.000878	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MDM2—malignant glioma	0.000286	0.000875	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RAF1—malignant glioma	0.000285	0.000872	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PIK3CB—malignant glioma	0.000284	0.000869	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ERBB2—malignant glioma	0.000282	0.000862	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PIK3CB—malignant glioma	0.000278	0.000851	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CXCL8—malignant glioma	0.000273	0.000835	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CXCL8—malignant glioma	0.000267	0.000818	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AKT1—malignant glioma	0.000264	0.000807	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CASP3—malignant glioma	0.000261	0.0008	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL2—malignant glioma	0.000261	0.000798	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AKT1—malignant glioma	0.000258	0.00079	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CASP3—malignant glioma	0.000256	0.000783	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL2—malignant glioma	0.000255	0.000781	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MMP9—malignant glioma	0.000247	0.000756	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PTEN—malignant glioma	0.000245	0.000751	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MMP9—malignant glioma	0.000242	0.00074	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PTEN—malignant glioma	0.00024	0.000735	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AKT1—malignant glioma	0.000239	0.000733	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AKT1—malignant glioma	0.000234	0.000717	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—VEGFA—malignant glioma	0.000222	0.000678	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—STAT3—malignant glioma	0.00022	0.000672	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—VEGFA—malignant glioma	0.000217	0.000664	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—STAT3—malignant glioma	0.000215	0.000658	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MYC—malignant glioma	0.000204	0.000624	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MYC—malignant glioma	0.0002	0.000611	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—EGFR—malignant glioma	0.0002	0.000611	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—EGFR—malignant glioma	0.000195	0.000598	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—KRAS—malignant glioma	0.000189	0.000577	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—KRAS—malignant glioma	0.000185	0.000565	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PIK3CA—malignant glioma	0.000173	0.00053	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PIK3CA—malignant glioma	0.00017	0.000519	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TP53—malignant glioma	0.000168	0.000513	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TP53—malignant glioma	0.000164	0.000502	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AKT1—malignant glioma	0.000141	0.000433	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AKT1—malignant glioma	0.000138	0.000424	CbGpPWpGaD
